Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS-Reference-Cited by-同舟云学术

Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS

Published:2023-06-06 Issue:23 Volume:100 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

van Unnik Jordi W.J.¹,Nikolakopoulos Stavros¹,Eijkemans Marinus J.C.¹,Gonzalez-Bermejo Jésus¹,Bruneteau Gaelle¹,Morelot-Panzini Capucine¹,van den Berg Leonard H.¹,Cudkowicz Merit E.¹,McDermott Christopher J.¹,Similowski Thomas¹,van Eijk Ruben P.A.¹^ORCID,

Affiliation:

1. From the Department of Neurology (J.W.J.v.U., L.H.v.d.B., R.P.A.v.E.), UMC Utrecht Brain Center, and Biostatistics & Research Support (S.N., M.J.C.E., R.P.A.v.E.), Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands; Sorbonne Université (J.G.-B., C.M.-P., T.S.), INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Département R3S; APHP ...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207306

Reference49 articles.

1. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?

2. ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?

3. The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future

4. Dose-ranging study of riluzole in amyotrophic lateral sclerosis

5. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial